Catherine Le Visage is a Research Director (INSERM DR2) and Deputy Director of the Regenerative Medicine and Skeleton (RMeS) laboratory at Nantes University, France. She trained as a Pharmacist and received her PhD in Pharmaceutical Sciences from University Paris 11, followed by postdoctoral research in the Biomedical Engineering Department at Johns Hopkins University (USA), focusing on stem cell-based regenerative approaches for intervertebral disc (IVD) repair.

In 2007, she joined INSERM in a tenured position to investigate cross-linked polysaccharide hydrogels as a platform for regenerative medicine. As a group leader within the "Skeletal Physiopathology and Joint Regenerative Medicine" team, her recent work focuses on innovative hydrogels as carriers of cells or bioactive molecules for treating IVD disease and osteoarthritis, as well as biofabrication tools for developing in vitro models.

She has authored 84+ ISI-indexed publications (h-index 45, ~5,700 citations) and holds 11 patents. She has been elected a member of the TERMIS-EU Council and the French Academy of Pharmacy, is an International Fellow of Tissue Engineering and Regenerative Medicine (FTERM), and serves as an Associate Editor for Biomaterials (Elsevier).

Osteoarthritis therapy, Stem cell therapy